Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01619813
Title Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications

prostate adenocarcinoma

Therapies

Docetaxel + Prednisone

Pelareorep

Age Groups: adult
Covered Countries CAN


No variant requirements are available.